Search

Mary Macdonald Phones & Addresses

  • 902 White Mountain Dr, Show Low, AZ 85901 (928) 205-3924
  • Ramona, CA
  • San Bernardino, CA
  • Pismo Beach, CA
  • Los Osos, CA
  • San Diego, CA

Work

Company: Biologics peptide chemistry, janssen r&d Jun 2010 Position: Senior research scientist

Education

School / High School: University of Kansas- Lawrence, KS 2000 Specialities: Ph.D. in Medicinal Chemistry

Images

Professional Records

License Records

Mary E Macdonald

License #:
RS145307A - Expired
Category:
Real Estate Commission
Type:
Real Estate Salesperson-Standard

Mary T Macdonald

License #:
3028462 - Expired
Category:
Health Care
Issued Date:
Mar 11, 1996
Effective Date:
Jan 1, 1901
Expiration Date:
Apr 30, 1999
Type:
Registered Nurse

Lawyers & Attorneys

Mary Macdonald Photo 1

Mary Macdonald - Lawyer

View page
ISLN:
901592208
Admitted:
1987
Mary Macdonald Photo 2

Mary Macdonald - Lawyer

View page
ISLN:
901592215
Admitted:
1987
Mary Macdonald Photo 3

Mary Macdonald - Lawyer

View page
Office:
Univ. of Calif.
ISLN:
905284147
Admitted:
1976
University:
University of California at Berkeley, A.B., 1969
Law School:
University of San Francisco, J.D., 1976

Medicine Doctors

Mary Macdonald Photo 4

Mary C. Macdonald

View page
Specialties:
General Surgery
Work:
Ashland Surgical Care
350 Hillcrest Dr STE 1, Ashland, OH 44805
(419) 281-0451 (phone), (419) 207-2641 (fax)
Education:
Medical School
Georgetown University School of Medicine
Graduated: 1986
Procedures:
Breast Biopsy
Colonoscopy
Hernia Repair
Laparoscopic Appendectomy
Mastectomy
Pilonidal Cyst Excision
Proctosigmoidoscopy
Small Bowel Resection
Upper Gastrointestinal Endoscopy
Appendectomy
Hemorrhoid Procedures
Laparoscopic Gallbladder Removal
Sigmoidoscopy
Skin Tags Removal
Conditions:
Abdominal Hernia
Appendicitis
Benign Neoplasm of Breast
Breast Disorders
Cholelethiasis or Cholecystitis
Languages:
English
Description:
Dr. MacDonald graduated from the Georgetown University School of Medicine in 1986. She works in Ashland, OH and specializes in General Surgery. Dr. MacDonald is affiliated with University Hospitals Samaritan Medical Center.
Mary Macdonald Photo 5

Mary S. Macdonald

View page
Specialties:
Hematology/Oncology
Work:
Charleston Hematology/Oncology Associates
125 Doughty St STE 500, Charleston, SC 29403
(843) 577-2276 (phone), (843) 577-6523 (fax)

Charleston Hematology Oncology Associates
2085 Henry Tecklenburg Dr FL 2, Charleston, SC 29414
(843) 577-6957 (phone), (843) 577-6523 (fax)
Languages:
English
Spanish
Description:
Ms. Macdonald works in Charleston, SC and 1 other location and specializes in Hematology/Oncology. Ms. Macdonald is affiliated with Bon Secours St Francis Hospital and Roper Hospital.
Mary Macdonald Photo 6

Mary Eileen MacDonald

View page
Specialties:
Anesthesiology
Education:
Loyola University Chicago (1984)

Resumes

Resumes

Mary Macdonald Photo 7

Mary Macdonald San Diego, CA

View page
Work:
Biologics Peptide Chemistry, Janssen R&D

Jun 2010 to 2000
Senior Research Scientist

Human BioMolecular Research Institute
San Diego, CA
Feb 2007 to May 2010
Associate Scientist

La Jolla Pharmaceutical Company
San Diego, CA
Nov 2002 to Nov 2006
Research Scientist

Department of Chemistry, The Scripps Research Institute
La Jolla, CA
Jan 2001 to Oct 2002
Postdoctoral Research Associate

Department of Medicinal Chemistry, University of Kansas
Lawrence, KS
Aug 1995 to Dec 2000
Graduate Research Assistant

Peptide Chemistry, Magainin Pharmaceuticals, Inc
Plymouth Meeting, PA
Apr 1990 to Jul 1995
Scientist

Education:
University of Kansas
Lawrence, KS
2000
Ph.D. in Medicinal Chemistry

Ursinus College
Collegeville, PA
1991
B.S. in Chemistry

Business Records

Name / Title
Company / Classification
Phones & Addresses
Mary Carey Macdonald
ASHLAND GENERAL SURGERY, LLC
Mary Macdonald
Director
ORANGE JULIUS OF AMERICA
Mary Macdonald
ASHLAND GENERAL SURGERY, INC

Publications

Wikipedia References

Mary Macdonald Photo 8

Mary Macdonald

Work:

The same year she was named as DBE Macdonald was falsely accused of assaulting a pupil at an assembly rehearsal.

Skills & Activities:
Ascribed status:

British of Scottish descent

Award:

Dames Commander of the Order of the British Empire

Isbn (Books And Publications)

Federal Grants for Vocational Rehabilitation

View page
Author

Mary E. MacDonald

ISBN #

0405131232

Teaching Information Literacy: 35 Practical, Standards-Based Exercises for College Students

View page
Author

Mary C. Macdonald

ISBN #

0838908543

Mararoko: A Study in Melanesian Religion

View page
Author

Mary N. MacDonald

ISBN #

0820411949

Reading Drills: Advanced Level

View page
Author

Mary M. MacDonald

ISBN #

0890610398

Fantasy

View page
Author

Mary Macdonald

ISBN #

0070263299

Fantasy

View page
Author

Mary Macdonald

ISBN #

0070263353

Noodles and Stevanoff

View page
Author

Mary Macdonald

ISBN #

0533101662

Pension Funds and Venture Capital: The Critical Links between Savings, Investment, Technology, and Jobs

View page
Author

Mary Macdonald

ISBN #

0662142322

Us Patents

Amine-Based And Amide-Based Inhibitors Of Semicarbazide-Sensitive Amine Oxidase (Ssao) Enzyne Activity And Vap-1 Mediated Adhesion Useful For Treatment Of Diseases

View page
US Patent:
20060025438, Feb 2, 2006
Filed:
Feb 25, 2005
Appl. No.:
11/066786
Inventors:
Luisa Salter-Cid - San Diego CA, US
Eric Wang - San Diego CA, US
Mary MacDonald - San Diego CA, US
Jingjing Zhao - San Diego CA, US
International Classification:
A61K 31/4745
A61K 31/165
A61K 31/47
A61K 31/137
US Classification:
514303000, 514309000, 514620000, 514649000
Abstract:
Compositions and methods are disclosed for inhibiting semicarbazide-sensitive amine oxidase (SSAO), also known as vascular adhesion protein-1 (VAP-1). The compounds disclosed are amine-containing and amide-containing compounds. The compounds and compositions are useful for treatment of diseases, including inflammation, inflammatory diseases and autoimmune disorders.

Inhibitors Of Semicarbazide-Sensitive Amine Oxidase (Ssao) And Vap-1 Mediated Adhesion Useful For Treatment And Prevention Of Diseases

View page
US Patent:
20070293548, Dec 20, 2007
Filed:
Mar 30, 2007
Appl. No.:
11/731819
Inventors:
Eric Wang - San Diego CA, US
David Jones - San Diego CA, US
Anne O'Rourke - Encinitas CA, US
Mary MacDonald - San Diego CA, US
Hongfeng Gao - San Diego CA, US
Huong-thu Ton-Nu - San Diego CA, US
Christina Kessler - San Diego CA, US
Matthew Linnik - Solana Beach CA, US
International Classification:
A61K 31/44
A61K 31/135
A61K 31/343
A61P 37/00
C07C 211/29
C07C 217/54
C07C 211/26
A61P 29/00
A61K 31/381
US Classification:
514357000, 514443000, 514469000, 514649000, 514651000, 564336000, 564346000, 564366000
Abstract:
Compositions and methods of using compositions for treatment of inflammatory diseases and immune disorders are provided. Allylamino compounds are disclosed which are inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and/or vascular adhesion protein 1 (VAP-1). The compounds have therapeutic utility in suppressing inflammation and inflammatory responses, and in treatment of several disorders, including multiple sclerosis and stroke.

Inhibitors Of Semicarbazide-Sensitive Amine Oxidase (Ssao) And Vap-1 Mediated Adhesion Useful For Treatment And Prevention Of Diseases

View page
US Patent:
20090203764, Aug 13, 2009
Filed:
Apr 20, 2009
Appl. No.:
12/426885
Inventors:
Eric Yanjun WANG - San Diego CA, US
David S. Jones - San Diego CA, US
Anne M. O'Rourke - Encinitas CA, US
Mary T. MacDonald - San Diego CA, US
Hongfeng Gao - San Diego CA, US
Huong-thu Ton-Nu - San Diego CA, US
Christina A. Kessler - San Diego CA, US
Matthew D. Linnik - Solana Beach CA, US
International Classification:
A61K 31/137
A61P 29/00
A61K 31/381
US Classification:
514438, 514649
Abstract:
Compositions and methods of using compositions for treatment of inflammatory diseases and immune disorders are provided. Allylamino compounds are disclosed which are inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and/or vascular adhesion protein 1 (VAP-1). The compounds have therapeutic utility in suppressing inflammation and inflammatory responses, and in treatment of several disorders, including multiple sclerosis and stroke.

Chemical And Biochemical Adducts As Biomarkers For Organophosphate Exposure

View page
US Patent:
20110236931, Sep 29, 2011
Filed:
Apr 14, 2009
Appl. No.:
12/937957
Inventors:
John R. Cashman - San Diego CA, US
Mary T. MacDonald - San Diego CA, US
Assignee:
HUMAN BIOMOLECULAR RESEARCH INSTITUTE - San Diego CA
International Classification:
C12P 21/00
C12P 21/08
C07K 19/00
C07K 7/06
C07K 7/08
C07K 14/00
C07F 9/40
US Classification:
435 7021, 435 702, 530409, 530329, 530328, 530327, 530326, 530325, 530324, 530395, 530363, 558172, 558190, 558166
Abstract:
Provided is a method to identify OP-adducted biomarkers of OP exposure as well as compounds containing OPs that can provide OP adducts.

Inhibitors Of Semicarbazide-Sensitive Amine Oxidase (Ssao) And Vap-1 Mediated Adhesion Useful For Treatment And Prevention Of Diseases

View page
US Patent:
20110269811, Nov 3, 2011
Filed:
May 3, 2011
Appl. No.:
13/100188
Inventors:
Eric Yanjun WANG - San Diego CA, US
David S. Jones - San Diego CA, US
Anne M. O'Rourke - Encinitas CA, US
Mary T. MacDonald - San Diego CA, US
Hongfeng Gao - San Diego CA, US
Huong-thu Ton-Nu - San Diego CA, US
Christina A. Kessler - San Diego CA, US
Matthew D. Linnik - Solana Beach CA, US
International Classification:
A61K 31/137
A61K 31/4035
A61P 29/00
A61P 25/00
A61P 1/00
A61P 1/04
A61P 25/28
A61P 9/10
A61P 19/02
A61P 11/06
A61P 17/00
A61P 1/16
A61P 3/10
A61P 9/04
A61P 37/00
A61K 31/145
US Classification:
514417, 514649
Abstract:
Compositions and methods of using compositions for treatment of inflammatory diseases and immune disorders are provided. Allylamino compounds are disclosed which are inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and/or vascular adhesion protein 1 (VAP-1). The compounds have therapeutic utility in suppressing inflammation and inflammatory responses, and in treatment of several disorders, including multiple sclerosis and stroke.

Amine-Based And Amide-Based Inhibitors Of Semicarbazide-Sensitive Amine Oxidase (Ssao) Enzyme Activity And Vap-1 Mediated Adhesion Useful For Treatment Of Diseases

View page
US Patent:
20120172392, Jul 5, 2012
Filed:
Mar 7, 2012
Appl. No.:
13/414644
Inventors:
LUISA M. SALTER-CID - PRINCETON JUNTION NJ, US
ERIC Y. WANG - SAN DIEGO CA, US
MARY T. MACDONALD - SAN DIEGO CA, US
JINGJING ZHAO - SAN DIEGO CA, US
International Classification:
A61K 31/164
A61K 31/166
C07D 217/24
A61K 31/472
C07D 209/46
A61K 31/4035
C07D 209/08
A61K 31/4045
C07D 249/18
A61K 31/4192
C07D 235/06
A61K 31/4184
C07D 231/56
A61K 31/416
C07C 211/30
A61K 31/137
C07D 207/20
A61K 31/40
C07D 213/30
A61K 31/4406
C07D 213/26
C07C 211/29
C07C 215/30
C07C 211/27
C07C 229/34
A61K 31/198
A61K 31/24
C07D 471/04
A61K 31/437
C07C 237/06
A61P 29/00
C07C 233/78
US Classification:
514303, 564187, 514617, 546141, 514309, 548472, 514416, 548469, 514415, 548257, 514359, 5483097, 514394, 5483625, 514406, 564387, 514655, 548565, 514408, 514428, 546339, 514277, 546346, 564366, 514649, 564355, 564381, 514653, 514654, 562449, 514567, 560 38, 514538, 546118, 564193, 514626
Abstract:
Compositions and methods are disclosed for inhibiting semicarbazide-sensitive amine oxidase (SSAO), also known as vascular adhesion protein-1 (VAP-1). The compounds disclosed are amine-containing and amide-containing compounds. The compounds and compositions are useful for treatment of diseases, including inflammation, inflammatory diseases and autoimmune disorders.

Chemical And Biochemical Adducts As Biomarkers For Organophosphate Exposure

View page
US Patent:
20170101441, Apr 13, 2017
Filed:
Dec 27, 2016
Appl. No.:
15/391614
Inventors:
- San Diego CA, US
Mary T. MacDonald - San Diego CA, US
Assignee:
Human BioMolecular Research Foundation - San Diego CA
International Classification:
C07K 7/06
C12P 21/00
C07K 16/18
Abstract:
Provided are methods for identifying OP-adducted biomarkers of OP exposure as well as compounds containing OPs that can provide OP adducts and compounds of Formula 1 for eliciting antibodies that specifically and selectively bind to the OP adducts, wherein the Formula 1 compounds have the structure of OP-Peptide-Linker-CP, wherein CP is a carrier protein, OP represents a structure corresponding to that of a reactive organic phosphorous compound covalently modifying a tyrosine residue hydroxyl group of the peptide of Formula I and the other variable groups are as described herein.
Mary Allison Macdonald from Show Low, AZ, age ~65 Get Report